|
|
Hokkaido University Collection of Scholarly and Academic Papers >
Showing results 1 to 9 of 9
| Type | Author(s) | Title | Other Titles | Citation | Citation(alt) | Issue Date | | article | Kawagishi, Naoki; Suda, Goki; Kimura, Megumi; Maehara, Osamu; Yamada, Ren; Tokuchi, Yoshimasa; Kubo, Akinori; Kitagataya, Takashi; Shigesawa, Taku; Suzuki, Kazuharu; Ohara, Masatsugu; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Kudo, Yusuke; Nishida, Mutsumi; Sakamoto, Naoya | Baseline elevated serum angiopoietin-2 predicts long-term non-regression of liver fibrosis after direct-acting antiviral therapy for hepatitis C | - | Scientific reports | - | 28-Apr-2021 |
| article | Shigesawa, Taku; Suda, Goki; Kimura, Megumi; Maehara, Osamu; Tokuchi, Yoshimasa; Kubo, Akinori; Yamada, Ren; Furuya, Ken; Baba, Masaru; Kitagataya, Takashi; Suzuki, Kazuharu; Ohara, Masatsugu; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Sakamoto, Naoya | Baseline serum angiopoietin-2 and VEGF levels predict the deterioration of the liver functional reserve during lenvatinib treatment for hepatocellular carcinoma | - | PLoS ONE | - | 1-Mar-2021 |
| article | Yang, Zijian; Suda, Goki; Maehara, Osamu; Ohara, Masatsugu; Yoshida, Sonoe; Hosoda, Shunichi; Kimura, Megumi; Kubo, Akinori; Tokuchi, Yoshimasa; Fu, Qingjie; Yamada, Ren; Kitagataya, Takashi; Suzuki, Kazuharu; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Ohnishi, Shunsuke; Sakamoto, Naoya | Changes in Serum Growth Factors during Lenvatinib Predict the Post Progressive Survival in Patients with Unresectable Hepatocellular Carcinoma | - | Cancers | - | 4-Jan-2022 |
| article | Kubo, Akinori; Suda, Goki; Kimura, Megumi; Maehara, Osamu; Tokuchi, Yoshimasa; Kitagataya, Takashi; Ohara, Masatsugu; Yamada, Ren; Shigesawa, Taku; Suzuki, Kazuharu; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Ohnishi, Shunsuke; Sakamoto, Naoya | Characteristics and Lenvatinib Treatment Response of Unresectable Hepatocellular Carcinoma with Iso-High Intensity in the Hepatobiliary Phase of EOB-MRI | - | Cancers | - | Jul-2021 |
| article | Sho, Takuya; Suda, Goki; Yamamoto, Yoshiya; Furuya, Ken; Baba, Masaru; Ogawa, Koji; Kubo, Akinori; Tokuchi, Yoshimasa; Fu, Qingjie; Yang, Zijian; Kimura, Megumi; Kitagataya, Takashi; Maehara, Osamu; Ohnishi, Shunsuke; Nakamura, Akihisa; Yamada, Ren; Ohara, Masatsugu; Kawagishi, Naoki; Natsuizaka, Mitsuteru; Nakai, Masato; Suzuki, Kazuharu; Izumi, Takaaki; Meguro, Takashi; Terashita, Katsumi; Takagi, Tomofumi; Ito, Jun; Kobayashi, Tomoe; Miyagishima, Takuto; Sakamoto, Naoya | Efficacy and Effect on Liver Functional Reserve of Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma in Patients Who Do Not Meet Eligibility Criteria of IMbrave150 | - | Cancers | - | 15-Aug-2022 |
| article | Hosoda, Shunichi; Suda, Goki; Sho, Takuya; Ogawa, Koji; Kimura, Megumi; Yang, Zijian; Yoshida, Sonoe; Kubo, Akinori; Tokuchi, Yoshimasa; Kitagataya, Takashi; Maehara, Osamu; Ohnishi, Shunsuke; Nakamura, Akihisa; Yamada, Ren; Ohara, Masatsugu; Kawagishi, Naoki; Natsuizaka, Mitsuteru; Nakai, Masato; Morikawa, Kenichi; Furuya, Ken; Baba, Masaru; Yamamoto, Yoshiya; Suzuki, Kazuharu; Izumi, Takaaki; Meguro, Takashi; Terashita, Katsumi; Ito, Jun; Miyagishima, Takuto; Sakamoto, Naoya | Low baseline CXCL9 predicts early progressive disease in unresectable HCC with atezolizumab plus bevacizumab treatment | - | Liver Cancer | - | Jun-2023 |
| article | Tokuchi, Yoshimasa; Suda, Goki; Kimura, Megumi; Maehara, Osamu; Kitagataya, Takashi; Kubo, Akinori; Yoshida, Sonoe; Fu, Qingjie; Yang, Zijian; Hosoda, Shunichi; Ohara, Masatsugu; Yamada, Ren; Suzuki, Kazuharu; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Ohnishi, Shunsuke; Sakamoto, Naoya | Possible correlation between increased serum free carnitine levels and increased skeletal muscle mass following HCV eradication by direct acting antivirals | - | Scientific reports | - | 16-Aug-2021 |
| article | Nakai, Masato; Yamamoto, Yoshiya; Baba, Masaru; Suda, Goki; Kubo, Akinori; Tokuchi, Yoshimasa; Kitagataya, Takashi; Yamada, Ren; Shigesawa, Taku; Suzuki, Kazuharu; Nakamura, Akihisa; Sho, Takuya; Morikawa, Kenichi; Ogawa, Koji; Furuya, Ken; Sakamoto, Naoya | Prediction of hepatocellular carcinoma using age and liver stiffness on transient elastography after hepatitis C virus eradication | - | Scientific reports | - | 27-Jan-2022 |
| article | Kawagishi, Naoki; Suda, Goki; Sakamori, Ryotaro; Matsui, Takeshi; Onozawa, Masahiro; Yang, Zijian; Yoshida, Sonoe; Ohara, Masatsugu; Kimura, Megumi; Kubo, Akinori; Maehara, Osamu; Fu, Qingjie; Hosoda, Shunichi; Tokuchi, Yoshimasa; Suzuki, Kazuharu; Nakai, Masato; Sho, Takuya; Morikawa, Kenichi; Natsuizaka, Mitsuteru; Ogawa, Koji; Sakai, Hajime; Ohnishi, Shunsuke; Baba, Masaru; Takehara, Tetsuo; Sakamoto, Naoya | Serum IL-1 beta predicts de novo hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C, not during anti-cancer/immunosuppressive therapy | - | Scientific reports | - | 7-Oct-2022 |
Showing results 1 to 9 of 9
|
